{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:59:04Z","timestamp":1774529944473,"version":"3.50.1"},"reference-count":36,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.nephro.2020.10.010","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T17:27:41Z","timestamp":1612718861000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Succ\u00e8s du traitement par paclitaxel d\u2019une rechute visc\u00e9rale d\u2019un sarcome de Kaposi apr\u00e8s transplantation r\u00e9nale"],"prefix":"10.1684","volume":"17","author":[{"given":"Amel","family":"Harzallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mondher","family":"Ounissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Hajji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumaya","family":"Chargui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafedh","family":"Hedri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezzeddine","family":"Abderrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fathi","family":"Ben Hamida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mongi","family":"Bacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taieb","family":"Ben Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2020.10.010_bib0185","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ijc.24741","article-title":"Cancer and viral infections in immunocompromised individuals","volume":"125","author":"Schulz","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nephro.2020.10.010_bib0190","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2019.03.028","article-title":"Management of Kaposi sarcoma after solid organ transplantation: a European retrospective study","volume":"81","author":"Delyon","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0195","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.1969.03150210077009","article-title":"Disseminated visceral Kaposi's sarcoma. Appearance after human renal homograft operation","volume":"207","author":"Siegel","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.nephro.2020.10.010_bib0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.medmal.2005.02.009","article-title":"Epidemiological aspects of human herpes virus 8\u00a0infection and of Kaposi's sarcoma","volume":"35","author":"Plancoulaine","year":"2005","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.nephro.2020.10.010_bib0205","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/00007890-200005150-00008","article-title":"Outcome of kidney transplant recipients with previous human herpes virus-8\u00a0infection","volume":"69","author":"Frances","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2020.10.010_bib0210","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1600-6143.2009.02816.x","article-title":"The impact of pre-existing or acquired Kaposi sarcoma herpes virus infection in kidney transplant recipients on morbidity and survival","volume":"9","author":"Frances","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2020.10.010_bib0215","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2020.10.010_bib0220","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/archderm.136.12.1452","article-title":"Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients","volume":"136","author":"Barete","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0225","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","article-title":"Conversion to sirolimus: a successful treatment for post-transplantation Kaposi's sarcoma","volume":"77","author":"Campistol","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2020.10.010_bib0230","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2006.01412.x","article-title":"Sirolimus conversion for patients with post-transplant Kaposi's sarcoma","volume":"6","author":"Lebbe","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2020.10.010_bib0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0b013e318193886e","article-title":"The role of mTOR inhibitors in the management of post-transplant malignancy","volume":"87","author":"Monaco","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2020.10.010_bib0240","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpes virus-like DNA sequences in AIDS associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nephro.2020.10.010_bib0245","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ijc.22233","article-title":"Kaposi's sarcoma risk among transplant recipients in the United States (1993\u20132003)","volume":"119","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nephro.2020.10.010_bib0250","first-page":"876","article-title":"Cancers in cyclosporine-treated vs. azathioprine-treated patients","volume":"28","author":"Penn","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nephro.2020.10.010_bib0255","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199709150-00001","article-title":"Kaposi's sarcoma in transplant recipients","volume":"64","author":"Penn","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2020.10.010_bib0260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2020.10.010_bib0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000184900","article-title":"Post-transplant Kaposi sarcoma: staging as a guide to therapy and prognosis","volume":"48","author":"Al-Khader","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2020.10.010_bib0270","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.transproceed.2005.07.042","article-title":"Outcome of Kaposi's sarcoma and graft following discontinuation of immunosuppressive drugs in renal transplant recipients","volume":"37","author":"Firoozan","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nephro.2020.10.010_bib0275","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199709150-00001","article-title":"Kaposi's sarcoma in transplant recipients","volume":"64","author":"Penn","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2020.10.010_bib0280","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2020.10.010_bib0285","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.1600-6143.2008.02391.x","article-title":"mTOR, cancer and transplantation","volume":"8","author":"Geissler","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2020.10.010_bib0290","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1681\/ASN.2005090993","article-title":"Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation","volume":"17","author":"Campistol","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0295","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomised controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0300","first-page":"339","article-title":"Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of \u00cele-de-France","volume":"2","author":"Farge","year":"1993","journal-title":"Eur J Med"},{"key":"10.1016\/j.nephro.2020.10.010_bib0305","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1182\/blood-2007-06-097568","article-title":"Phase\u00a02\u00a0study of pegylated liposomal doxorubicin in combination with interleukin-12\u00a0for AIDS-related Kaposi sarcoma","volume":"110","author":"Little","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nephro.2020.10.010_bib0310","first-page":"4095","article-title":"Efficacy of paclitaxel in the treatment of Kaposi sarcoma","volume":"19","author":"Ercolak","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.nephro.2020.10.010_bib0315","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1034\/j.1600-6143.2002.20911.x","article-title":"Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel","volume":"2","author":"Patel","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2020.10.010_bib0320","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0041-1345(00)00922-2","article-title":"Results of treatment in renal transplant patients with Kaposi sarcoma: one-centre experience","volume":"32","author":"Arican","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nephro.2020.10.010_bib0325","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2020.10.010_bib0330","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":"Randomised trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.nephro.2020.10.010_bib0335","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.1999.17.6.1876","article-title":"Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma","volume":"17","author":"Gill","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0340","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.10634","article-title":"Multicentre trial of low dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma","volume":"95","author":"Tulpule","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.nephro.2020.10.010_bib0345","unstructured":"Bristol-Myers Squibb Company. Taxol (paclitaxel) injection. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/020262s049lbl.pdf. (derni\u00e8rement acc\u00e9d\u00e9 le 28\u00a0d\u00e9cembre 2015)."},{"key":"10.1016\/j.nephro.2020.10.010_bib0350","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4049\/jimmunol.165.1.509","article-title":"Mechanism of paclitaxel activity in Kaposi's sarcoma","volume":"165","author":"Sgadari","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0355","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5021\/ad.2011.23.4.504","article-title":"Treatment of disseminated classic type of Kaposi's sarcoma with paclitaxel","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.nephro.2020.10.010_bib0180","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1365-4632.2006.03142.x","article-title":"Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy","volume":"45","author":"Baskan","year":"2006","journal-title":"Int J Dermatol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725520304156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725520304156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2020.10.010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:12:22Z","timestamp":1741191142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725520304156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1769725520304156"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2020.10.010","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Succ\u00e8s du traitement par paclitaxel d\u2019une rechute visc\u00e9rale d\u2019un sarcome de Kaposi apr\u00e8s transplantation r\u00e9nale","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2020.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}